CORE
🇺🇦
make metadata, not war
Services
Services overview
Explore all CORE services
Access to raw data
API
Dataset
FastSync
Content discovery
Recommender
Discovery
OAI identifiers
OAI Resolver
Managing content
Dashboard
Bespoke contracts
Consultancy services
Support us
Support us
Membership
Sponsorship
Community governance
Advisory Board
Board of supporters
Research network
About
About us
Our mission
Team
Blog
FAQs
Contact us
Filters
1 research outputs found
Interim Results of A Randomized Phase II Trial of Azacitidine (AZA) +/− Epo In Lower Risk Myelodysplastic Syndrome (MDS) Resistant to An Erythropoietic Stimulating Agent (ESA) Alone
Author
Agnès Guerci
Aspasia Stamatoulas
+28 more
Bachra Choufi
Borhane Slama
Christian Récher
Claude Gardin
Denis Caillot
E. Wattel
Emmanuel Raffoux
Eng-Mong Lim
Fatiha Chermat
Francois Dreyfus
Françoise Isnard
Gandhi Damaj
Gerard Tertian
Jacques Delaunay
Laurence Legros
Laurence Sanhes
Lydia Roy
MP Chaury
N. Cambier
Norbert Vey
Odile Beyne-Rauzy
Pierre Fenaux
Simone Boehrer
Sophie Park
Stephane Cheze
Sylvie Chevret
Thomas Prebet
Tony Jernival
Publication venue
'American Society of Hematology'
Publication date
Field of study
No full text
Crossref